Sequential bronchoplastic lobectomies in complex treatment for synchronous bilateral multiple primary non-small cell lung cancer: a rare clinical case

Today, lung cancer (LC) occupies a special place in the oncological general morbidity among the male population both in Russia and in foreign countries. Despite modern diagnostic capabilities provided for modern physicians, steadily frequent cases of triggering and exclusion are more common in patients older than 60–65 years. Surgery is the main treatment for early-stage non-small cell lung cancer (NSCLC), but as the disease progresses, unfortunately, its effectiveness decreases. The strategy of diagnosing and treating patients with one NSCLC has been developed and worked out for a long time and does not cause any difficulties, but in the presence of two or more tumors, especially when they are located in both lungs, the correct choice of therapy is determined by many additional factors. This article describes the rare use of extended bronchoplastic upper lobectomy as a surgical component of the complex treatment of a patient with bilateral synchronous NSCLC. Based on our own observational data, it can be claimed that the use of modern therapeutic principles in combination with surgical intervention allows achieving satisfactory long-term results in the treatment of patients with primary multiple NSCLC.

The interest of the presented observation is based on the fact that it contains a description of a rare and unique application of sequential extended bronchoplastic upper lobectomy as a surgical component of the complex treatment of a patient with bilateral synchronous NSCLC, which we have not found analogues in the literature. We have shown that the consistent use of modern therapeutic modalities makes it possible to achieve satisfactory long-term results in the treatment of a locally advanced disease. 

1. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Ed. by A. D. Kaprin, V. V. Starinsky, A. O. Shakhzadova. Мoscow: P. A. Herzen Moscow State Medical Research Institute – Branch of the National Medical Research Radiological Center, 2021, 252 p. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2021/11/zis-2020-elektronnaya-versiya.pdf, Accessed: 29.10.2022.

2. Kharagezov DA, Lazutin YuN, Mirzoyan EA, Milakin AG, Stateshny ON, Leyman IA. Neoadjuvant and adjuvant immunotherapy for non-small cell lung cancer (literature review). Problems in Oncology. 2022;68(2):159-168. (In Russ.). https://doi.org/10.37469/0507-3758-2022-68-2-159-168

3. Kharagezov DA, Lazutin YuN, Mirzoyan EA, Milakin AG, Stateshny ON, Leiman IA, et al. Lung cancers biomarkers. Research and Practical Medicine Journal. 2022;9(1):103–116. (In Russ.). https://doi.org/10.17709/2410-1893-2022-9-1-9

4. Romaszko AM, Doboszyńska A. Multiple primary lung cancer: A literature review. Adv Clin Exp Med. 2018;27(5):725-730. https://doi.org/10.17219/acem/68631

5. Tanvetyanon T, Finley DJ, Fabian T, Riquet M, Voltolini L, Kocaturk C, et al. Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data. Ann Oncol. 2013 Apr;24(4):889–894. https://doi.org/10.1093/annonc/mds495

6. Gwendolyn HM, Griffioen GH, Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, et al. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery. Radiother Oncol. 2013 Jun;107(3):403–408. https://doi.org/10.1016/j.radonc.2013.04.026

7. Riquet M, Cazes A, Pfeuty K, Ngabou UD, Foucault C, Dujon A, et al. Multiple lung cancers prognosis: what about histology? Ann Thorac Surg. 2008 Sep;86(3):921–926. https://doi.org/10.1016/j.athoracsur.2008.05.041

8. De Leyn P, Moons J, Vansteenkiste J, Verbeken E, Van Raemdonck D, Nafteux P, et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg. 2008 Dec;34(6):1215–1222. https://doi.org/10.1016/j.ejcts.2008.07.069

9. Yang H, Sun Y, Yao F, Yu K, Gu H, Han B, et al. Surgical Therapy for Bilateral Multiple Primary Lung Cancer. Ann Thorac Surg. 2016 Mar;101(3):1145–1152. https://doi.org/10.1016/j.athoracsur.2015.09.028

10. Lazutin YuN, Sergostyants GZ, Pyltsin SP, Kharitonova AP, Leyman IA. Method of treating lung cancer. The patent of the Russian Federation No 2554750. 27.06.2015. (In Russ.).